01
Latest News/ Blog
Gene Solutions to Showcase Latest Data on Multi-omics and AI for Precision Oncology at ESMO Asia Congress 2025
Gene Solutions will present latest advancements in multi-omics integration and AI-powered analytics for precision oncology at the European Society for Medical Oncology (ESMO) Asia Congress 2025, taking place December 5–7
SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine
Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has become a global trend, and Taiwan joins this movement
MCED and Traditional Screening: A Comprehensive, Complementary Strategy
Traditional cancer screenings such as mammography and colonoscopy remain essential tools that have reduced cancer deaths for decades. Yet, these tests only cover a few cancer types and depend on
New Study Validates Tumor-Naïve, Multi-omics ctDNA Assay Performance for MRD Detection and Recurrence Prediction Across Solid Tumors
Real-world evidence shows high specificity and practical utility when tissue is unavailable, supporting relapse prediction, treatment surveillance and real-time resistance monitoring. Gene Solutions today announced the publication of a new
Highlight Takeaways from the APAC Precision Oncology Conference 2025
On November 1, Hong Kong hosted a regional meeting focused on the evolving role of precision oncology. The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in
A guide to Multi-Cancer Early Detection Testing (MCED) in Asia
MCED testing is emerging as an innovative solution in the fight against cancer, offering the ability to detect multiple types of cancer at earlier stages with just a single test.
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials
Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant
Gene Solutions Spotlights Genomic Innovations at IASLC Asia Conference on Lung Cancer (ACLC) 2025
Ho Chi Minh City, October 2025 – Gene Solutions proudly participated as a sponsor at the IASLC Asia Conference on Lung Cancer (ACLC) 2025, held in Ho Chi Minh City
EARLY DETECTION SAVES LIVES — AND AWARENESS DRIVES ACTION
During Breast Cancer Awareness Month (October), Dr. Angela Pang, Senior Medical Oncologist at OncoCare Cancer Center, joined the 365 Cancer Prevention Society’s live broadcast to raise awareness about cancer prevention
Hoan My Medical Group and Gene Solutions Sign Strategic Partnership: Expanding Access to International-Standard Genetic Testing
Ho Chi Minh City, October 15, 2025 – Hoan My Medical Group and Gene Solutions held a strategic partnership signing ceremony, attended by Ms. Huynh Bich Lien, Chief Executive Officer
Gene Solutions Showcases MRD and Multi-Omics Advances at Singapore Society of Oncology Annual Scientific Meeting 2025
Gene Solutions hosted a landmark symposium titled “Advancing Precision Oncology: Molecular Residual Disease (MRD) and Multi-Omics in Solid Tumors” at the Singapore Society of Oncology (SSO) Annual Scientific Meeting, held
Clinical Case: Outsmarting Breast Cancer with Multi-Omics ctDNA
Overview Breast cancer is the second most common cancer worldwide, accounting for more than 600,000 deaths annually (1). Despite remarkable advances in early detection and treatment—leading to a 99% survival
02
Press release
SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine
Key finding:
TAIPEI, Nov. 28, 2025 /PRNewswire/ — Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has become a global trend, and Taiwan joins this movement with the introduction of SPOT-MAS – an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health.Authors:
Gene Solutions Genomics Pte Ltd
AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment
Key finding:
HONG KONG, Nov. 17, 2025 /PRNewswire/ — The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a clear message: AI and multi-omics are no longer theoretical – they are driving real-world advancements in cancer care across the Asia-Pacific (APAC) region.Authors:
Gene Solutions Genomics Pte Ltd
Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials
Key finding:
Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of Understanding (MOU) on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025
Key finding:
At the Singapore Society of Oncology Annual Scientific Meeting 2025 (SSO ASM 2025), Gene Solutions showcased how Molecular Residual Disease (MRD) and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore’s role as a hub for innovation and global collaboration.Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India
Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
Key finding:
Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU).Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions and Topgen Join Forces to Advance Precision Oncology All Over China
Key finding:
Gene Solutions has formalized a strategic collaboration with Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., a CAP-accredited laboratory with a well-established footprint across all over China.Authors:
Gene Solutions Genomics Pte Ltd
Illuminating ctDNA-MRD: Gene Solutions’ K-CONNECT APAC 2025 Sparks Regional Collaboration in Precision Oncology
Key finding:
Gene Solutions, a pioneer in AI-driven precision oncology hosted K-CONNECT APAC 2025, a pivotal summit uniting over 100 distinguished oncologists and molecular biologists from nine Asia-Pacific countries. — This landmark event marked a significant milestone in advancing precision oncology, fostering collaboration, and driving innovation in the fields of circulating tumor DNA (ctDNA), Molecular Residual Disease (MRD), and Comprehensive Genomic Profiling (CGP).Authors:
Gene Solutions Genomics Pte Ltd
SPOT-MAS Lung: AI-Powered Blood Test Brings New Hope to High-Risk Non-Smokers in Asia
Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions and NEWCL Forge Strategic Partnership to Advance Genetic Testing in Taiwan
Key finding:
NEW TAIPEI CITY, May 16, 2025 — In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan’s pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan. This collaboration was sealed with the signing of a Memorandum of Understanding (MoU) at NEWCL’s state-of-the-art facility in New Taipei City.Authors:
Gene Solutions Genomics Pte Ltd
Gene Solutions and Element Biosciences Enter Strategic Collaboration to Advance Next-Generation Sequencing (NGS) Technology Globally
Key finding:
HO CHI MINH CITY, April 22, 2025 /PRNewswire/ — Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have entered into a strategic collaboration. The collaboration was formalized with the signing of a Memorandum of Understanding (MoU) during Element Biosciences’ visit to Gene Solutions’ laboratory.
Asia’s First Real-World ctDNA-MRD Study Strengthens Evidence for Cost-Effective Cancer Monitoring
Key finding:
SINGAPORE, April 19, 2025 /PRNewswire/ — Gene Solutions, a biotechnology company dedicated to advancing precision oncology in Asia, is excited to announce the publication of a pioneering real-world study in JCO Oncology Advances, validating circulating tumor DNA (ctDNA) as a strong prognostic biomarker to effectively monitor patients during cancer management.
